Rituximab Induces Remission in Refractory HCV Associated Cryoglobulinaemic Vasculitis

Annals of the Rheumatic Diseases- United Kingdom

doi 10.1136/ard.2002.004929

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

December 1, 2003

Authors

Publisher

BMJ

Related search

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports

English

Complete Remission Induced by Rituximab in Refractory, Seronegative, Muscle-Specific, Kinase-Positive Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry

English

Microscopic Haematuria in ANCA-Associated Vasculitis With Glomerulonephritis During Treatment and Remission

Journal of Vasculitis

English

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Activation-Induced Cytidine Deaminase in B Cells of Hepatits C Virus-Related Cryoglobulinaemic Vasculitis

Clinical and Experimental Immunology

English

Two Cases of Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Internal Medicine

Internal Medicine

English

Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab

BMJ Case Reports

English

Rituximab for Refractory Wegener's Granulomatosis

American Journal of Respiratory and Critical Care Medicine

Respiratory Medicine

Intensive Care Medicine

English